Testosterone Patents

Given below is the list of patents protecting Testosterone, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Testosterone's patents.

Latest Legal Activities on Testosterone's Patents

Given below is the list recent legal activities going on the following patents of Testosterone.

Activity	Date	Patent Number
Today's Critical Events
Expire Patent Critical	17 Jun, 2024	US8178518(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity	12 Jun, 2024	US9662340
Maintenance Fee Reminder Mailed Critical	01 Jan, 2024	US8178518(Litigated)
Expire Patent Critical	25 Dec, 2023	US8063029(Litigated)
Maintenance Fee Reminder Mailed Critical	10 Jul, 2023	US8063029(Litigated)
Expire Patent Critical	05 Jun, 2023	US7935690(Litigated)
Maintenance Fee Reminder Mailed Critical	19 Dec, 2022	US7935690(Litigated)
Expire Patent Critical	29 Nov, 2021	US7608606(Litigated)
Expire Patent Critical	29 Nov, 2021	US7608605(Litigated)
Expire Patent Critical	29 Nov, 2021	US7608607(Litigated)

Testosterone's Family Patents

Full family tree